AzTrials
AzTrials

Fibromuscular DysplasiaNCT07526766

A Study Of Exercise In Patients With Spontaneous Coronary Artery Dissection And Fibromuscular Dysplasia

A study testing Aerobic and resistance exercises in people with Fibromuscular Dysplasia and Spontaneous Coronary Artery Dissection, run by Mayo Clinic at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record

Search all trials

Trial summary

The purpose of this study is to assess the cardiopulmonary, hemodynamic, and symptom responses to acute bouts of varying intensity aerobic and resistance exercise in people with Spontaneous Coronary Artery Dissection (SCAD) and/or Fibromuscular Dysplasia (FMD). Read more about this study

Who is it for?
Ages 21 to 65 years
What is being tested?
Aerobic and resistance exercises
Could I receive a placebo?
No, everyone receives an active treatment
How many people
28 participants
Where
1 siteUnited States
Study dates
1 Sep 2026to 1 Nov 2027
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • History of Spontaneous Coronary Artery Dissection (SCAD) and/or Fibromuscular Dysplasia (FMD), ≥2 months post-event, and free from chest pain.
  • Able to provide written informed consent

Who cannot join

  • Individuals who are clinically obese (BMI ≥36) and/or who suffer from musculoskeletal or other conditions that would limit exercise participation.
  • Individuals who are deemed medically unstable
  • Participants who are unable to comply with study requirements.
  • Pregnancy

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Armia R. Habil, MD contact

904-953-0859

habil.armia@mayo.edu

United States1 site, 1 recruiting
  • Mayo Clinic in Florida

    Jacksonville, Florida, 32224

    Armia R. Habil, MD, 904-953-0859, habil.armia@mayo.edu

    Elizabeth H. Dineen, DO

    Recruiting

Other trials in United States

About this study

Official title: Cardiopulmonary, Hemodynamic, And Symptom Responses To Aerobic And Resistance Exercise In Patients With Spontaneous Coronary Artery Dissection And Fibromuscular Dysplasia: A Single-center, Single-arm Prospective Clinical Trial.

The purpose of this study is to assess the cardiopulmonary, hemodynamic, and symptom responses to acute bouts of varying intensity aerobic and resistance exercise in people with Spontaneous Coronary Artery Dissection (SCAD) and/or Fibromuscular Dysplasia (FMD).

Being tested
Aerobic and resistance exercises
Medical subject headings
Fibromuscular Dysplasia, Coronary Artery Dissection, Spontaneous

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Aerobic and resistance exercisesBehavioural

    Subjects will undergo three exercise tests, each separated by at least 48 hours:

    • Symptom-limited cardiopulmonary exercise test (CPET): Patients will cycle upright starting at 0W (3 min) before the workload is increased by 10-35W·min-1 in a ramp fashion (like cycling up a progressively steeper hill) until volitional exhaustion for the determination of V̇O2peak and Wpeak
    • Two-stage submaximal constant power exercise test: Following a 5-minute warm-up (10-20 W), participants will cycle in the moderate intensity domain for 25 minutes followed by 25 minutes in the heavy intensity domain.
    • Six different resistance exercises of varying intensities: Participants will perform three sets of six different resistance exercises: chest press; lateral raises; abdominal crunches; planks; leg press; weighted lunges
Study groups in NCT07526766
Study groupRoleWhat they receive
Aerobic and resistance exerciseExperimentalPatients with a history of Spontaneous Coronary Artery Dissection and/or Fibromuscular Dysplasia will undergo three exercise tests.
Receives: Behavioral: Aerobic and resistance exercises

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in blood pressure in response to aerobic exercise

    Systemic blood pressure will be measured at rest, at peak exercise, and for 5 minutes of recovery after exercise via finger photoplethysmography and reported as mmHg

    Measured: Baseline, 5 minutes, 25 minutes, 50 minutes and 55 minutes

  2. Dartmouth COOP Functional Assessment Chart score

    The Dartmouth COOP Functional Assessment Charts are a set of patient-reported, pictorial tools used to measure physical, mental, and social functioning. The tool includes 9 questions that are rated on scores from 1-5, with higher scores indicating worse function.

    Measured: Baseline

  3. Duke Activity Index Status (DASI) score

    The Duke Activity Status Index (DASI) is a self-administered questionnaire that measures a patient's functional capacity. It consists of 12 yes/no questions. Scores range from 0 to 58.2, with higher scores indicating better exercise capacity.

    Measured: Baseline

  4. International Physical Activity Questionnaire Short Form (IPAQ-SF) score

    The International Physical Activity Questionnaire Short Form (IPAQ-SF) is a 7-item self-reported questionnaire where subjects report time spent being physically active in the last 7 days reported hours per day or minutes per day.

    Measured: Baseline

  5. Change in perceived exertion

    Perceived exertion (breathlessness and leg fatigue) will be obtained using the Borg 0-10 scale.

    Measured: Baseline, 25 minutes, and 50 minutes

  6. Change in blood lactate concentration [La-]b

    Blood lactate concentration [La-]b will be measured via analysis of a pinprick point-of-care lactate test (via the earlobe) at rest, during exercise, and at peak exercise.

    Measured: Baseline, 25 minutes, and 50 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Apr 2026
  2. Study start1 Sep 2026
  3. Primary completion30 Aug 2027 (estimated)
  4. Study completion1 Nov 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
28 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07526766
Sponsor's protocol ID
25-011057
Status last verified
Oct 2026
First submitted
6 Apr 2026
Last updated
22 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in